While this fundamentally conservative approach avoids risky investment, it arguably comes with a significant opportunity cost ( a key lesson of the 2012 Presidential campaign): a missed chance to take advantage of technologies already available and to gain expertise in navigating this important, emerging space.
FORBES: Pharma's Digital Health Strategy: Four Options